Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

CSL Stock News

CSLLYOTCQX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$78.35

-0.80-1.01%

At close: -

$78.35

0.000.00%

After Hours: 4:00 PM EDT

CSL (CSLLY) Forecast

News

Earnings CSL (CSLLY) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest CSL Stock News | OTC:CSLLY | Benzinga

Get the latest news on CSL stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on CSL performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, February 07, 2025

uniQure/ CSL Behring's Hemophilia Gene Therapy Shows Sustained Efficacy and Safety At Four Years
Vandana Singh - Feb 7, 2025, 1:04PM

Monday, October 07, 2024

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor - Oct 7, 2024, 7:19AM

Friday, October 04, 2024

GSK, Sanofi, And CSL Secure US Government Fund To Boost Bird Flu Vaccine Production: Report
Vandana Singh - Oct 4, 2024, 12:31PM
U.S. HHS Official Says BARDA Awarding Additio...
Benzinga Newsdesk - Oct 4, 2024, 11:09AM

Monday, September 30, 2024

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
Vandana Singh - Sep 30, 2024, 11:12AM

Thursday, July 11, 2024

Akebia And CSL Vifor Have Terminated The Lice...
Benzinga Newsdesk - Jul 11, 2024, 6:04AM

Tuesday, July 02, 2024

US HHS Says 8 Labs Sign Royalty-Free Agreemen...
Benzinga Newsdesk - Jul 2, 2024, 10:58AM

Monday, May 20, 2024

CSL and Arcturus Therapeutics Announce Nature...
Benzinga Newsdesk - May 20, 2024, 8:42AM

Tuesday, April 30, 2024

ARS Pharmaceuticals Submits Response For neff...
Benzinga Newsdesk - Apr 30, 2024, 9:23AM

Friday, April 26, 2024

FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Vandana Singh - Apr 26, 2024, 2:30PM

Friday, February 23, 2024

Travere Therapeutics And CSL Vifor Announced ...
Benzinga Newsdesk - Feb 23, 2024, 7:07AM

Wednesday, December 13, 2023

Arcturus Therapeutics' Lung Disease Candidate Triggers Bullish Rating, Analyst Sees Over 200% Upside
Vandana Singh - Dec 13, 2023, 1:34PM

Monday, March 20, 2023

Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
Vandana Singh - Mar 20, 2023, 10:00AM
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
Vandana Singh - Mar 20, 2023, 7:54AM

Tuesday, February 21, 2023

Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment
Vandana Singh - Feb 21, 2023, 7:41AM

Wednesday, November 23, 2022

FDA Approves UniQure's Hemgenix, First Hemophilia B Gene Therapy For Adults
Vandana Singh - Nov 23, 2022, 8:12AM

Wednesday, November 02, 2022

Arcturus Shares Jump After Collaboration With CSL For mRNA-Based Vaccines
Vandana Singh - Nov 2, 2022, 7:43AM

Monday, August 22, 2022

Travere, CSL's Sparsentan Application Is Under European Review For Rare Kidney Disorder
Vandana Singh - Aug 22, 2022, 9:58AM

Wednesday, August 17, 2022

CSL Posts Encouraging Data From Garadacimab In Severe Swelling Attacks
Vandana Singh - Aug 17, 2022, 12:10PM

Friday, May 13, 2022

The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Vandana Singh - May 13, 2022, 10:38AM

Tuesday, December 14, 2021

CSL Seals $11.7B Buyout Deal Of Vifor Pharma, Probably the Largest Healthcare Deal In 2021
Vandana Singh - Dec 14, 2021, 2:36PM

Wednesday, March 03, 2021

COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial
Vandana Singh - Mar 3, 2021, 5:20AM

Sunday, November 08, 2020

CSL Announced Commencement of Manufacturing of University of Oxford/AstraZeneca Vaccine Candidate in Melbourne
Charles Gross - Nov 8, 2020, 7:53AM

Tuesday, March 24, 2020

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights - Mar 24, 2020, 11:39AM
Stocks That Hit 52-Week Highs On Tuesday
Benzinga Insights - Mar 24, 2020, 11:35AM

Wednesday, February 19, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin - Feb 19, 2020, 10:32AM

Wednesday, February 12, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin - Feb 12, 2020, 11:45AM

Tuesday, February 11, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin - Feb 11, 2020, 10:17AM

Thursday, February 06, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin - Feb 6, 2020, 10:39AM

Tuesday, February 04, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin - Feb 4, 2020, 10:18AM

Wednesday, January 29, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin - Jan 29, 2020, 10:16AM

Friday, January 24, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin - Jan 24, 2020, 10:41AM

Wednesday, January 22, 2020

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin - Jan 22, 2020, 10:17AM

Tuesday, January 21, 2020

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin - Jan 21, 2020, 10:11AM

Thursday, January 16, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin - Jan 16, 2020, 10:22AM

Friday, January 10, 2020

Stocks That Hit 52-Week Highs On Friday
Lisa Levin - Jan 10, 2020, 12:18PM

Thursday, January 09, 2020

Stocks That Hit 52-Week Highs On Thursday
Lisa Levin - Jan 9, 2020, 3:15PM

Monday, December 02, 2019

Stocks That Hit 52-Week Highs On Monday
Lisa Levin - Dec 2, 2019, 10:15AM

Friday, November 29, 2019

Stocks That Hit 52-Week Highs On Friday
Lisa Levin - Nov 29, 2019, 10:28AM

Wednesday, November 27, 2019

Stocks That Hit 52-Week Highs On Wednesday
Lisa Levin - Nov 27, 2019, 10:14AM

Tuesday, November 26, 2019

Stocks That Hit 52-Week Highs On Tuesday
Lisa Levin - Nov 26, 2019, 11:03AM

Friday, October 11, 2019

Stocks That Hit 52-Week Highs On Friday
Lisa Levin - Oct 11, 2019, 10:18AM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved